This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Colorectal Cancer in Patients with Early ... New research indicates that colorectal cancer diagnosed at an ... (22 Mar 2019)
Improved the gut of IBS-patients with ... Transplantation of feces from a healthy person to a patient ... (22 Mar 2019)
A television in the bedroom? Having a television in the bedroom during the preschool years ... (21 Mar 2019)
Commonly used heart drug associated with ... A drug commonly used to treat high blood pressure and angina is ... (17 Mar 2019)
Anti-vaccination activists using new ... Anti-vaccination activists are capitalising on radical new ... (20 Mar 2019)

Ian Ellul

Dr Ian Ellul PhD[Paed.][Melit.] has been the managing editor of The Synapse Journal since 2005. He was also Director of Pharmacy Services at a private hospital group, the government's Clinical Trials Coordinator for trials conducted in Malta, as well as senior regulatory affairs officer.  

 

by Ian Ellul 

Wednesday, 23 January 2019 21:23

Moorfields Eye Hospital, AI & paradigm shifts

By Ian Ellul - The application of AI in medicine has always intrigued clinicians, so much so that Elsevier started publishing the journal Artificial Intelligence in Medicine way back in 1989. 

Tuesday, 22 January 2019 20:46

An island, Brexit & a most perfect storm

by Dr Ian Ellul - On 29 March 2017, the European Council received the notification by the UK of its intention to withdraw from the EU.

Thursday, 08 November 2018 20:14

UK’s Breast Cancer Screening Glitch

by Ian Ellul - Last May, Health Secretary Jeremy Hunt announced that 450,000 women between the ages of 68 and 71 in the UK failed to receive invitations for a final routine breast cancer screening.

Friday, 18 May 2018 20:45

Gene Editing … Quo Vadis?

Ian Ellul - As discussed in the last editorial, modern gene editing is quite precise but it is not perfect.

Wednesday, 16 May 2018 20:07

Nip and Tuck … Embrace the Future

I wish to start 2018 by discussing gene editing which, following last year’s remarkable advances, is rumoured to continue to make a star appearance on stage. Gene editing basically rewrites DNA, disabling target genes, correcting harmful mutations and changing the activity of specific genes.

Page 1 of 9

TheSynapse Magazines

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…